Publication | Open Access
Early Treatment of High-Risk Hospitalized Coronavirus Disease 2019 (COVID-19) Patients With a Combination of Interferon Beta-1b and Remdesivir: A Phase 2 Open-label Randomized Controlled Trial
26
Citations
24
References
2022
Year
NCT04647695.
| Year | Citations | |
|---|---|---|
Page 1
Page 1